Back to Market Feed

PRALUENT 75 MG/ML PEN

alirocumab
$258.0650per ML

Strength

75 mg/mL

NDC

61755002002

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/16/2026

Active Ingredients

ALIROCUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125559

On Market Since

12/1/2020

Pharmacological Classes

Antibodies
Monoclonal
PCSK9 Inhibitor
PCSK9 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.9%

1Y

+2.8%

3Y

+8.4%

5Y

N/A

All

+18.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

REPATHA 140 MG/ML SYRINGE
Brand
72511050101•Amgen Inc.
$281.2448
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511075001•Amgen Inc.
$281.2448
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511039302•Amgen Inc.
$281.9492
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511076002•Amgen Inc.
$281.9492
per ML
DUPIXENT 300 MG/2 ML PEN
Brand
00024591502•Sanofi-Aventis U.S. LLC
$1008.4070
per ML
DUPIXENT 300 MG/2 ML SYRINGE
Brand
00024591401•Sanofi-Aventis U.S. LLC
$1009.9578
per ML
DUPIXENT 200 MG/1.14 ML PEN
Brand
00024591902•Sanofi-Aventis U.S. LLC
$1772.9914
per ML
DUPIXENT 200 MG/1.14 ML SYRING
Brand
00024591801•Sanofi-Aventis U.S. LLC
$1774.7544
per ML